• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC PUERTO RICO OPERATIONS CO. ACTIVA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR ESSENTI

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC PUERTO RICO OPERATIONS CO. ACTIVA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR ESSENTI Back to Search Results
Model Number 37612
Device Problem Delayed Charge Time (2586)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Event Description
It was reported that the recharger was taking much long than normal to charge the ins.The patient stated that it normally took them about 1.5 hours to charge the ins from 50% to 100%, but in "probably" the last couple of months it has been taking 2.5-3 hours to charge the ins from 50% to 100%.The patient noted that they used to split up ins recharge sessions between 2 nights, and now they have to split it up between 3 nights because of the increased ins recharge duration.The patient confirmed that they always get excellent coupling.The patient stated that they reported this issue to their healthcare provider at an appointment on (b)(6) 2022, and the hcp told the patient that they would reach out to the manufacturer's representative (rep).The patient mentioned they had the appointment with their hcp to have their programming checked; no allegations were made regarding therapy.The hcp also advised the patient to call patient services because they thought the recharger might be "wearing out".The patient mentioned that their hcp told them that their ins "runs at a high voltage." the patient understood that ins recharge sessions take longer as the hcp "bumps up the voltage," but they stated that the voltage was not up so high that it would result in ins recharge sessions taking twice as long as normal.During the call, the patient was charging their ins and confirmed that all 8 coupling bars were filled in.The patient denied any falls or trauma prior to this event.The issue was not resolved.An email was sent to the repair department to replace the recharger.The patient was advised to have their hcp check the ins if the replacement recharger does not resolve the issue.Additional information was received from a healthcare provider, via the manufacturer¿s representative (rep), who reported the patient was concerned recharging was taking a long time (the patient was on high settings).Additional information was received from the consumer who reported that recharging was still taking 3.5 to 4 hours (in one hour stints) to fully charge after receiving the replacement recharger.It was reported that it used to take them 2.5 to 3 hours to go from 25% to full.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received from the consumer who reported that the cause of the charge duration issue was not determined.The steps taken to resolve the issue was the patient got a different charger and there was no change.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACTIVA
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR ESSENTI
Manufacturer (Section D)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer (Section G)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer Contact
glen belmer
7000 central avenue ne rcw215
minneapolis, MN 55432
6122713209
MDR Report Key14687730
MDR Text Key302365097
Report Number3004209178-2022-07594
Device Sequence Number1
Product Code PJS
UDI-Device Identifier00643169529762
UDI-Public00643169529762
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P960009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 07/06/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/14/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/14/2018
Device Model Number37612
Device Catalogue Number37612
Was Device Available for Evaluation? No
Date Manufacturer Received07/01/2022
Date Device Manufactured11/16/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient SexMale
Patient Weight82 KG
-
-